Article Data

  • Views 262
  • Dowloads 101

Original Research

Open Access

Outcomes of conservative surgery in early epithelial ovarian carcinoma

  • X. Cheng1
  • B. Cheng1,*,
  • X. Wan1
  • W. Lu1
  • X. Xie1

1Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, Hangzhou, China

DOI: 10.12892/ejgo20120193 Vol.33,Issue 1,January 2012 pp.93-95

Published: 10 January 2012

*Corresponding Author(s): B. Cheng E-mail: chengbei128@gmail.com

Abstract

Objective: To investigate clinical outcomes and fertility status of conservative treatment for epithelial ovarian carcinoma. Methods: The data of clinicopathological characteristics and follow-up were retrospectively collected and analyzed in 17 patients with early epithelial ovarian carcinoma who underwent conservative surgery. Results: The tumor histologic types of 17 patients included 13 mucinous, one serous, one endometrioid, and two mixed mucinous and serous carcinomas. The FIGO stages were: ten Stage IA, six IC, and one IIIA disease. Tumor grades involved 15 grade 1 and two grade 2. Sixteen patients received adjuvant platinum-based combined chemotherapy. The medium duration of follow-up was 61 months (range 17 similar to 115 months). Only one patient recurred at 36 months after primary surgery. All of the 17 patients were alive at end of follow-up. Eight patients attempted pregnancy and five patients conceived naturally; there were six term pregnancies and one abortion. Conclusion: Conservative surgery can be considered for young patients with FIGO Stage I including grade 1 and grade 2 epithelial ovarian cancers who desire further childbearing.

Keywords

Epithelial ovarian carcinoma; Conservative surgery; Recurrence; Pregnancy

Cite and Share

X. Cheng,B. Cheng,X. Wan,W. Lu,X. Xie. Outcomes of conservative surgery in early epithelial ovarian carcinoma. European Journal of Gynaecological Oncology. 2012. 33(1);93-95.

References

[1] 25th FIGO annual report on the results of treatment in gynecological cancer. Int. J. Gynecol. Obstet., 2003, 83 (suppl. 1), ix-xxii, 1.

[2] Munnel E.W.: “Is conservative therapy ever justified in Stage I (Ia) cancer of the ovary?”. Am. J. Obstet. Gynecol., 1969, 103, 641.

[3] Zanetta G., Chiari S., Rota S., Bratina G., Maneo A., Torri V. et al.: “Conservative surgery for Stage I ovarian carcinoma in women of childbearing age”. Br. J. Obstet. Gynaecol., 1997, 104, 1030.

[4] Schilder J.M., Thompsom A.M., DePriest P.D., Ueland F.R., Cibull M.L., Kryscio R.J. et al.: “Outcome of reproductive age women with Stage IA and IC invasive epithelial ovarian cancer treated with fertility-sparing therapy”. Gynecol. Oncol., 2002, 87, 1.

[5] Raspagliesi F., Fontanelli R., Paladini D., di Re E.M.: “Conservative surgery in high-risk epithelial ovarian carcinoma”. J. Am. Coll. Surg., 1997, 185, 457.

[6] Morice P., Wicart-Poque F., Rey A., El-Hassan J., Pautier P., Lhomme C. et al.: “Results of conservative treatment in epithelial ovarian carcinoma”. Cancer, 2001, 92, 2412.

[7] Morice P., Leblanc E., Rey A., Baron M., Querleu D., Blanchot J. et al.: “Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Française d’Oncologie Gynécologique)”. Hum. Reprod., 2005, 20, 1379.

[8] Park J.Y., Kim D.Y., Suh D.S., Kim J.H., Kim Y.M., Kim Y.T. et al.: “Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes”. Gynecol. Oncol., 2008, 110, 345.

[9] Colombo N., Chiari S., Maggioni A., Bocciolone L., Torri V., Mangioni C.: “Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy”. Gynecol. Oncol., 1994, 55, S47.

[10] Duska L.R., Chang Y.C., Flynn C.E., Chen A.H., Goodman A., Fuller A.F. et al.: “Epithelial ovarian carcinoma in the reproductive age group”. Cancer, 1999, 85, 2623.

[11] Brown C., Hyman J., Almadrones L., Curtin J., Hoskins W.: “Conservative surgical management of early epithelial ovarian cancer (EOC)”. Proc. ASCO, 1995, 14, 766.

[12] Douglas N.C., Fan L., Pothuri B., Herzog T.J., Sauer M.V.: “Fertility sparing therapy for ovarian cancer has inherent risks and benefits”. Arch. Gynecol. Obstet., 2005, 272, 304.

[13] Zanagnolo V., Sartori E., Trussardi E., Pasinetti B., Maggino T.: “Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 123, 235.

[14] Borgfeldt C., Iosif C., Masback A.: “Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2007, 134, 110.

[15] Shimizu Y., Hasumi K., Kamoi S., Amada S., Silverberg S.G.: “A new histopathologic grading system for ovarian carcinoma”. Int. J. Gynecol. Obstet., 2000, 70 (suppl. 4), D38.

[16] Colombo N., Parma G., Lapresa M.T., Maggi F., Plantanida P., Maggioni A.: “Role of conservative surgery in ovarian cancer: the European experience”. Int. J. Gynecol. Cancer, 2005, 15 (suppl. 3), 206.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top